30
Participants
Start Date
April 20, 2017
Primary Completion Date
March 26, 2018
Study Completion Date
April 30, 2018
Reslizumab
Reslizumab 3 mg/kg once / every 4 weeks during 24 weeks
Hospital Reina Sofía, Córdoba
Hospital Universitario Lucus Augusti, Lugo
Hospital Universitario La Paz, Madrid
Hospital Virgen Del Rocío, Seville
Hospital Universitario Dr. Peset, Valencia
Hospital Universitario de Cruces, Barakaldo
Hospital Galdakao-Usansolo, Galdakao
Hospital Universitari Son Espases, Palma
Hospital de Sabadell, Sabadell
Hospital Clínic i Provincial de Barcelona, Barcelona
Teva Pharmaceuticals USA
INDUSTRY
Sociedad Española de Neumología y Cirugía Torácica
OTHER